ALT
Price
$6.30
Change
+$0.28 (+4.65%)
Updated
Oct 11 closing price
23 days until earnings call
VKTX
Price
$65.84
Change
+$3.39 (+5.43%)
Updated
Oct 11 closing price
17 days until earnings call
Ad is loading...

ALT vs VKTX

Header iconALT vs VKTX Comparison
Open Charts ALT vs VKTXBanner chart's image
Altimmune
Price$6.30
Change+$0.28 (+4.65%)
Volume$1.87M
CapitalizationN/A
Viking Therapeutics
Price$65.84
Change+$3.39 (+5.43%)
Volume$3.33M
CapitalizationN/A
View a ticker or compare two or three
ALT vs VKTX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. VKTX commentary
Oct 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongSell and VKTX is a Buy.

COMPARISON
Comparison
Oct 14, 2024
Stock price -- (ALT: $6.30 vs. VKTX: $65.84)
Brand notoriety: ALT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 82% vs. VKTX: 109%
Market capitalization -- ALT: $459.83M vs. VKTX: $7.02B
ALT [@Biotechnology] is valued at $459.83M. VKTX’s [@Biotechnology] market capitalization is $7.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VKTX is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 3 bullish, 6 bearish.
  • VKTX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а +1.12% price change this week, while VKTX (@Biotechnology) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

VKTX is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($7.02B) has a higher market cap than ALT($460M). VKTX YTD gains are higher at: 253.788 vs. ALT (-44.000). ALT has higher annual earnings (EBITDA): -100.91M vs. VKTX (-124.38M). VKTX has more cash in the bank: 942M vs. ALT (165M). VKTX has less debt than ALT: VKTX (1.1M) vs ALT (1.86M). ALT has higher revenues than VKTX: ALT (409K) vs VKTX (0).
ALTVKTXALT / VKTX
Capitalization460M7.02B7%
EBITDA-100.91M-124.38M81%
Gain YTD-44.000253.788-17%
P/E RatioN/AN/A-
Revenue409K0-
Total Cash165M942M18%
Total Debt1.86M1.1M169%
FUNDAMENTALS RATINGS
ALT vs VKTX: Fundamental Ratings
ALT
VKTX
OUTLOOK RATING
1..100
5690
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
8225
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
5335
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (63) in the Biotechnology industry is in the same range as ALT (83) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's Profit vs Risk Rating (25) in the Biotechnology industry is somewhat better than the same rating for ALT (82) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew somewhat faster than ALT’s over the last 12 months.

VKTX's SMR Rating (93) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as ALT (53) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that VKTX’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
BTC.X62851.375000-341.648440
-0.54%
Bitcoin cryptocurrency
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla